Table of Contents
ISRN Pharmacology
Volume 2014, Article ID 530931, 7 pages
Research Article

An Improved Experimental Model of Hemorrhoids in Rats: Evaluation of Antihemorrhoidal Activity of an Herbal Formulation

Department of Pharmacology, R&D Center, The Himalaya Drug Company, Makali, Bangalore, Karnataka 562 162, India

Received 12 December 2013; Accepted 3 February 2014; Published 11 March 2014

Academic Editors: S. Cuzzocrea and G. B. Kaplan

Copyright © 2014 Mohammed Azeemuddin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Lohsiriwat, “Hemorrhoids: from basic pathophysiology to clinical management,” World Journal of Gastroenterology, vol. 18, no. 17, pp. 2009–2017, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Kaidar-Person, B. Person, and S. D. Wexner, “Hemorrhoidal disease: a comprehensive review,” Journal of the American College of Surgeons, vol. 204, no. 1, pp. 102–117, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. S. Chong and D. C. C. Bartolo, “Hemorrhoids and Fissure in Ano,” Gastroenterology Clinics of North America, vol. 37, no. 3, pp. 627–644, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Nishiki, K. Nishinaga, D. Kudoh, and K. Iwai, “Croton oil-induced hemorrhoid model in rat: comparison of anti-inflammatory activity of diflucortolone valerate with other glucocorticoids,” Nihon Yakurigaku Zasshi, vol. 92, no. 4, pp. 215–225, 1988 (Japanese). View at Google Scholar · View at Scopus
  5. G. Dibyendu, B. B. Manasi, R. C. Shankar, and J. Pramanik, “Clinical safety and efficacy of Pilex tablets and ointment in management of hemorrhoids,” International Journal of Clinical Practice, vol. 22, no. 9, pp. 443–448, 2012. View at Google Scholar
  6. M. Sahu and S. Pankaj, “Clinical study of Pilex combination therapy vs conventional ayurvedic therapy in management of haemorrhoids,” The Indian Practitioner, vol. 54, no. 11, pp. 799–805, 2001. View at Google Scholar
  7. A. Tripathi, “Comparative evaluation of Pilex with Daflon in haemorrhoids,” The Antiseptic, vol. 9, no. 97, p. 317, 2000. View at Google Scholar
  8. C. S. Vastrad and R. V. Pakkanavar, “Clinical evaluation of PIL-28, a herbal formulation in the management of hemorrhoids,” The Antiseptic, vol. 9, no. 99, pp. 343–344, 2002. View at Google Scholar
  9. World Health Organization, General Guidelines for Methodologies Research and Evaluation of Traditional Medicine, vol. 1, World Health Organization, Geneva, Switzerland, 2000.
  10. The Ayurvedic Pharmacopoeia of India Government of India, “Ministry of Health and Family Welfare Department of Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homeopathy,” New Delhi, vol. 2, no. 1, pp. 133–246, 2007.
  11. K. Nishiki, D. Kudoh, K. Nishinaga, K. Iwai, and H. Nakagawa, “Neriproct: its anti-inflammatory effect on an experimentally induced hemorrhoid model in the rat,” Nihon Yakurigaku Zasshi, vol. 92, no. 4, pp. 227–240, 1988 (Japanese). View at Google Scholar · View at Scopus
  12. M. Okumura, “Preparation for treating wounds or hemorrhoids,” US Patent no. 5403867, 1995.
  13. M. Yamabe, T. Hosokawa, T. Taoka, and M. Misawa, “A new pharyngitis model using capsaicin in rats,” General Pharmacology, vol. 30, no. 1, pp. 109–114, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Dallal and S.-W. Chang, “Evans blue dye in the assessment of permeability-surface area product in perfused rat lungs,” Journal of Applied Physiology, vol. 77, no. 2, pp. 1030–1035, 1994. View at Google Scholar · View at Scopus
  15. A. F. Carol and M. W. Timothy, “Cytokines in acute and chronic inflammation,” Frontiers in Bioscience, vol. 2, pp. 12–26, 1997. View at Google Scholar
  16. M. Yasmina, A. Carlos, J. P. Maria, and K. Agnieszka, “Evaluation of Evans blue extravasation as a measure of peripheral inflammation,” Protocol Exchange, 2010. View at Publisher · View at Google Scholar
  17. P. W. Hamer, J. M. McGeachie, M. J. Davies, and M. D. Grounds, “Evans blue dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability,” Journal of Anatomy, vol. 200, no. 1, pp. 69–79, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Akihisa, T. Noto, A. Takahashi et al., “Melanogenesis inhibitory, anti-inflammatory, and chemopreventive effects of limonoids from the seeds of Azadirachta indicia A. Juss. (Neem),” Journal of Oleo Science, vol. 58, no. 11, pp. 581–594, 2009. View at Google Scholar · View at Scopus
  19. M. Z. Asmawi, H. Kankaanranta, E. Moilanen, and H. Vapaatalo, “Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts,” Journal of Pharmacy and Pharmacology, vol. 45, no. 6, pp. 581–584, 1993. View at Google Scholar · View at Scopus
  20. S. Sireeratawong, K. Jaijoy, W. Panunto, and N. Soonthornchareonnon, “Anti-inflammatory activity of the water extract of Terminalia chebula Retz in rats,” Planta Medica, vol. 78, p. 112, 2012. View at Google Scholar
  21. S. K. Gupta, R. Agarwal, S. Srivastava et al., “The anti-inflammatory effects of Curcuma longa and Berberis aristata in endotoxin-induced uveitis in rabbits,” Investigative Ophthalmology and Visual Science, vol. 49, no. 9, pp. 4036–4040, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Saha, E. V. S. Subrahmanyamb, K. S. Chandrashekarc, and C. S. Shashidhara, “In vivo study for anti-inflammatory activity of Bauhinia variegata L. leaves,” Pharmaceutical Crops, vol. 2, pp. 70–73, 2011. View at Google Scholar
  23. S. H. Sukhdev, D. R. Dev, and V. Karan, Compendium of Medicinal and Aromatic Plants, vol. 2, ICS-UNIDO, Trieste, Italy, 2006.